858 Therapeutics
ID: 7729724858 Therapeutics develops small molecule drugs targeting oncology and immunology.
1
Funding Rounds
$60.0m
Money raised
Recent Funding Rounds
Overview
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Gr****** Ba** |
|
- | |
| Je***** St****** |
|
- | |
| Ji* Ve** |
|
- |
| Name | Phone | Social networks | |
|---|---|---|---|
| Al* Be******* | - | - | |
| Ca*** Ri***** | - | - | - |
| Cl*** Oz*** | - | - |
Funding series
Funding Series Analysis
The company 858 Therapeutics has raised a total of $60m in funding over 1 rounds.
Key Insights:
- 858 Therapeutics Series A round, September 2021: $60m
Industries
858 Therapeutics is active in the following industries: